- Home
- SPNT vs BCRX Comparison
SPNT vs BCRX Comparison
Compare SPNT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNT
- BCRX
- Stock Information
- Founded
- SPNT 2011
- BCRX 1986
- Country
- SPNT Bermuda
- BCRX United States
- Employees
- SPNT N/A
- BCRX N/A
- Industry
- SPNT Property-Casualty Insurers
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPNT Finance
- BCRX Health Care
- Exchange
- SPNT Nasdaq
- BCRX Nasdaq
- Market Cap
- SPNT 2.1B
- BCRX 1.8B
- IPO Year
- SPNT N/A
- BCRX 1994
- Fundamental
- Price
- SPNT $18.92
- BCRX $7.91
- Analyst Decision
- SPNT Buy
- BCRX Strong Buy
- Analyst Count
- SPNT 3
- BCRX 10
- Target Price
- SPNT $24.00
- BCRX $16.70
- AVG Volume (30 Days)
- SPNT 929.7K
- BCRX 2.2M
- Earning Date
- SPNT 10-30-2025
- BCRX 11-03-2025
- Dividend Yield
- SPNT N/A
- BCRX N/A
- EPS Growth
- SPNT N/A
- BCRX N/A
- EPS
- SPNT 0.75
- BCRX N/A
- Revenue
- SPNT $2,793,700,000.00
- BCRX $557,506,000.00
- Revenue This Year
- SPNT N/A
- BCRX $41.37
- Revenue Next Year
- SPNT $6.45
- BCRX $7.56
- P/E Ratio
- SPNT $25.18
- BCRX N/A
- Revenue Growth
- SPNT 3.57
- BCRX 45.85
- 52 Week Low
- SPNT $12.78
- BCRX $6.02
- 52 Week High
- SPNT $21.03
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- SPNT 54.69
- BCRX 35.17
- Support Level
- SPNT $18.50
- BCRX $7.93
- Resistance Level
- SPNT $19.15
- BCRX $8.13
- Average True Range (ATR)
- SPNT 0.44
- BCRX 0.22
- MACD
- SPNT 0.07
- BCRX -0.03
- Stochastic Oscillator
- SPNT 67.37
- BCRX 5.70
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.